Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia and Predominant Negative Symptoms”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT00725075
What this trial is testing

Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 215
Large-scale testing (Phase 3)Study completedNCT00145496
What this trial is testing

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)

Who this might be right for
Schizophrenia
Organon and Co 468
Testing effectiveness (Phase 2)Study completedNCT00922272
What this trial is testing

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Who this might be right for
Schizophrenia and Predominant Negative Symptoms
Shire 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07759895
What this trial is testing

Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia

Who this might be right for
Schizoaffecitve DisorderSchizophrenia and Schizoaffective DisorderSchizophrenia and Predominant Negative Symptoms
Amit Lotan 80
Large-scale testing (Phase 3)Study completedNCT00212836
What this trial is testing

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)

Who this might be right for
Schizophrenia
Organon and Co 481
Large-scale testing (Phase 3)Ended earlyNCT01760889
What this trial is testing

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 1
Large-scale testing (Phase 3)Study completedNCT01192906
What this trial is testing

RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 624
Large-scale testing (Phase 3)Ended earlyNCT01738698
What this trial is testing

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 4
Large-scale testing (Phase 3)Study completedNCT01192867
What this trial is testing

RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 629
Large-scale testing (Phase 3)Ended earlyNCT01760993
What this trial is testing

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 2
Large-scale testing (Phase 3)Study completedNCT01192880
What this trial is testing

Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 625
Not applicableLooking for participantsNCT07428460
What this trial is testing

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia and Predominant Negative Symptoms
Douglas Mental Health University Institute 75
Large-scale testing (Phase 3)WithdrawnNCT01234298
What this trial is testing

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Negative Symptoms of Schizophrenia
Shire